150mg Noxalk Ceritinib Capsules

150mg Noxalk Ceritinib Capsules Specification

Dosage Form
Oral

Packaging Type
Blister Pack

Life Span
2 years from date of manufacture

Indication
ALK-positive metastatic non-small cell lung cancer

Salt Composition
Ceritinib

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 capsules

Brand Name
Noxalk

Drug Type
Targeted therapy, prescription only

Ingredients
Ceritinib (150mg)

Physical Form
Capsules

Function
Anti-cancer, ALK inhibitor

Recommended For
Non-Small Cell Lung Cancer (NSCLC) patients

Dosage
As directed by physician, typically 450 mg to 750 mg once daily

Dosage Guidelines
Swallow whole, do not crush or chew. Take on an empty stomach.

Suitable For
Adults

Quantity
Box of 30 capsules

Storage Instructions
Store below 30C, protect from moisture and light

ATC Code
L01XE28

Barcode
Available on secondary packaging

Side Effects
Nausea, diarrhea, increased liver enzymes, vomiting, fatigue, abdominal pain

Prescription
Required

Marketed By
Natco Pharma Limited

Color
Opaque/gold cap and white body capsule

Pregnancy Category
Category D

MRP
As per pack

Warning
Not to be used in children, or in pregnancy and lactation unless prescribed

Caution
Not recommended for patients with severe hepatic impairment.

Patient Advice
Regular liver function monitoring recommended; avoid grapefruit and St. John's wort.

Therapeutic Class
Antineoplastic agents

Administration Route
Oral

150mg Noxalk Ceritinib Capsules Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About 150mg Noxalk Ceritinib Capsules

Manufacturer	Natco
Strength	150 mg
Packaging Size	90 Capsules
Brand	Noxalk
Composition	Ceritinib
Treatment	Anti Cancer
Pack Type	Box

Indication. Noxalk is used for the treatment of non-small cell lung cancer.Precaution. Noxalk is a prescription drug and should be used under proper medical guidance and advice.

Effective Targeted Therapy for ALK-Positive NSCLC

Noxalk Ceritinib 150mg is a specialized therapy formulated to target and inhibit ALK-positive cancer cells in non-small cell lung cancer (NSCLC). Designed for adults, this oral medication aids in managing advanced or metastatic cases by interfering with cancer cell growth and proliferation. Its efficacy lies in its role as an ALK inhibitor, providing a tailored approach for patients with a specific genetic profile.

Strict Usage and Monitoring Guidelines

Adherence to physician's instructions is essential when taking Noxalk Ceritinib. Capsules should be swallowed whole on an empty stomach, typically at a daily dose of 450 mg to 750 mg. Patients are advised to undergo regular liver function tests during treatment and avoid grapefruit or St. John's wort due to potential interactions. The medicine is not recommended for children or individuals with severe hepatic impairment.

Trusted Quality and Safe Handling

Manufactured in India by Natco Pharma Limited, Noxalk Ceritinib comes in blister packs, with clear instructions for storage, handling, and disposal to ensure patient safety. Each pack, with a two-year shelf life, provides clear labeling and a barcode for authenticity. The medication should be stored below 30C, protected from moisture and light, and kept out of reach of children.

FAQ's of 150mg Noxalk Ceritinib Capsules:

Q: How does Noxalk Ceritinib 150mg work in treating ALK-positive non-small cell lung cancer?

A: Noxalk Ceritinib functions as an ALK (anaplastic lymphoma kinase) inhibitor, effectively targeting and blocking the activity of the ALK protein that aids cancer cell growth. By interfering with this pathway, the medication helps reduce or slow the progression of ALK-positive NSCLC.

Q: What is the recommended way to take Noxalk Ceritinib capsules?

A: Noxalk Ceritinib capsules should be swallowed whole with water, not crushed or chewed, and taken on an empty stomach as directed by your physician. The usual daily dosage ranges from 450 mg to 750 mg, depending on individual medical direction.

Q: When should patients seek medical advice while using Noxalk Ceritinib?

A: Patients should contact their doctor immediately if they experience severe side effects such as persistent nausea, vomiting, diarrhea, fatigue, abdominal pain, or signs of increased liver enzymes. Regular liver function monitoring is crucial during therapy.

Q: Where should Noxalk Ceritinib capsules be stored for optimal safety and effectiveness?

A: Store Noxalk Ceritinib capsules below 30C in a dry place, protected from light and moisture. Keep the medication in its original blister packaging and away from the reach of children.

Q: What are the main benefits of using Noxalk Ceritinib in NSCLC therapy?

A: The primary benefit of Noxalk Ceritinib is its targeted mechanism against ALK-positive cancer cells, which can improve disease management and slow cancer advancement, thereby enhancing patient outcomes in cases of advanced NSCLC.

Q: Is Noxalk Ceritinib safe for use during pregnancy or in children?

A: No, Noxalk Ceritinib is not recommended for children or during pregnancy and lactation unless specifically prescribed by a healthcare professional, due to potential risks and lack of safety data in these populations.

Q: What precautions should patients be aware of when using Noxalk Ceritinib?

A: Patients should avoid consuming grapefruit or St. John's wort, as they may interfere with Ceritinib's effectiveness. It is also not suitable for those with severe hepatic impairment, and ongoing medical monitoring is advised throughout the treatment period.